1094101-31-1Relevant articles and documents
Twin medicine type HMG-CoA reductase inhibiting agent and synthesis method thereof
-
Paragraph 0022; 0023; 0024; 0055; 0056; 0057, (2017/10/18)
The invention belongs to the technical field of medicine chemistry, and particularly relates to a first-class twin medicine type HMG-CoA reductase inhibiting agent and a synthesis method thereof. The preparation method of the novel twin medicine type HMG-CoA reductase inhibiting agent has the advantages that the reaction steps are simple; no pollution exists; the method is suitable for industrial scaled application; the activity of the HMG-CoA reductase inhibiting agent is obviously superior to that of positive control medicine.